Results 341 to 350 of about 6,512,999 (388)
The Precision-Guided Use of PI3K Pathway Inhibitors for the Treatment of Solid Malignancies. [PDF]
Schmitz AE+3 more
europepmc +1 more source
PD-1/PD-L1 inhibitor-induced hyponatremia: a real-world pharmacovigilance analysis using FAERS database. [PDF]
Tao C+10 more
europepmc +1 more source
Matrix Metalloproteinases and Their Inhibitors in the Pathogenesis of Epithelial Differentiation, Vascular Disease, Endometriosis, and Ocular Fibrotic Pterygium. [PDF]
Park JY+5 more
europepmc +1 more source
Identification of novel HER2 ınhibitors: potential therapeutics for breast cancer. [PDF]
Yalaza C+5 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
A metalloproteinase inhibitor as an inhibitor of neovascularization
Journal of Cellular Biochemistry, 1991AbstractMetalloproteinases and their endogenous inhibitors are key components of an enzyme system which is important in a number of fundamental biochemical and cellular processes. Our recent work has focused on the role of a particular metalloproteinase, collagenase, and the role of an endogenous inhibitor of this enzyme in the control of ...
Robert Langer+2 more
openaire +3 more sources
Specificity and mechanism of action of some commonly used protein kinase inhibitors.
Biochemical Journal, 2000The specificities of 28 commercially available compounds reported to be relatively selective inhibitors of particular serine/threonine-specific protein kinases have been examined against a large panel of protein kinases.
S. Davies+3 more
semanticscholar +1 more source
ChemInform Abstract: PROTEINASE INHIBITORS. 1. INHIBITORS OF ELASTASE
Chemischer Informationsdienst, 1977Abstract36 Peptid‐carbazate werden in Tabellen aufgeführt und als Inhibitoren von Elastase geprüft z.B. Vertreter der Art (V) und (VI).
Shu Shu Yang+6 more
openaire +4 more sources
Farnesyltransferase inhibitors versus Ras inhibitors
Current Opinion in Chemical Biology, 1997Over the past few years, the idea that farnesyl-protein transferase (FPTase) inhibitors might be effective antiproliferative/antitumor agents has been realized in studies of cultured cells and in rodent models of cancer. Most of the studies with FPTase inhibitors have focused on inhibiting the growth of ras-transformed cells in vitro or the growth of ...
Charles A. Omer+6 more
openaire +3 more sources